Cargando…

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis

Detalles Bibliográficos
Autor principal:	Bose, Poulomee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034275/ https://www.ncbi.nlm.nih.gov/pubmed/31823882 http://dx.doi.org/10.4103/1673-5374.270309

Ejemplares similares

Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
por: Cappello, Valentina, et al.
Publicado: (2017)

Neuromuscular junction mitochondrial enrichment: a “double-edged sword” underlying the selective motor neuron vulnerability in amyotrophic lateral sclerosis
por: Altman, Topaz, et al.
Publicado: (2020)

Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
por: Krakora, Dan, et al.
Publicado: (2012)

Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS)
por: Alhindi, Abrar, et al.
Publicado: (2021)

The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis
por: Pollari, Eveliina, et al.
Publicado: (2014)

Adducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for Dear Life
por: Krieger, Charles, et al.
Publicado: (2016)

Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
por: Campanari, Maria-Letizia, et al.
Publicado: (2016)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)

Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?
por: Carreras, Francisco Javier
Publicado: (2016)

Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis
por: Picchiarelli, Gina, et al.
Publicado: (2019)

Fibrosis as a common trait in amyotrophic lateral sclerosis tissues
por: Apolloni, Savina, et al.
Publicado: (2021)

Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis
por: Lo, Martin W., et al.
Publicado: (2020)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis
por: Kanekura, Kohsuke, et al.
Publicado: (2022)

Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis
por: Rizzuto, Emanuele, et al.
Publicado: (2015)

Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions
por: Pereira, João D., et al.
Publicado: (2021)

Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2016)

Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis
por: Barnes, Stephanie L, et al.
Publicado: (2019)

Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis
por: Zhang, Yongguo, et al.
Publicado: (2021)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

Combination of novel RNA sequencing and sophisticated network modeling to reveal a common denominator in amyotrophic lateral sclerosis?
por: Dash, Banaja P., et al.
Publicado: (2023)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

Mending the broken in amyotrophic lateral sclerosis: DNA damage and repair in motor neuron degeneration
por: Kim, Byung Woo, et al.
Publicado: (2020)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia
por: ROWLAND, L.P.
Publicado: (2011)

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?
por: Allen, Scott P.
Publicado: (2020)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Fused in sarcoma-amyotrophic lateral sclerosis as a novel member of DNA single strand break diseases with pure neurological phenotypes
por: Naumann, Marcel, et al.
Publicado: (2020)

Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1(G93A) mice
por: Shapiro, Dillon, et al.
Publicado: (2022)

Medium-Chain Fatty Acids Rescue Motor Function and Neuromuscular Junction Degeneration in a Drosophila Model of Amyotrophic Lateral Sclerosis
por: Dunn, Ella, et al.
Publicado: (2023)

Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)
por: Limpert, Allison S, et al.
Publicado: (2013)

Progress in perisynaptic Schwann cell and neuromuscular junction research
por: Walker, Chandler L.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hvj9vvokoaqp3i6s6om5boc3pm